Inhibitory effects of dendrobium alkaloids on memory impairment induced by lipopolysaccharide in rats

Planta Medica

Volumn 77, Issue 2, 2011, Pages 117-121

  Li, Yanfei ^a   Li, Fei ^a   Gong, Qihai ^a   Wu, Qin ^b   Shi, Jingshan ^a,b  

^a ZUNYI MEDICAL UNIVERSITY   (China)

^b Key Laboratory of Basic Pharmacology of Guizhou   (China)

Author keywords

Dendrobium alkaloids; Dendrobium nobile Lindl.; lipopolysaccharide; Morris water maze; nuclear factor kappaB; Orchidaceae; pp38 MAPK; TNFR1

Indexed keywords

ALKALOID; DENDROBIUM ALKALOID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; TUMOR NECROSIS FACTOR RECEPTOR 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN VENTRICLE; COGNITION; CONTROLLED STUDY; DENDROBIUM; DRUG INHIBITION; GENE OVEREXPRESSION; INHIBITION KINETICS; MALE; MAZE TEST; MEMORY DISORDER; NONHUMAN; PROTEIN PHOSPHORYLATION; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ALKALOIDS; ANIMALS; DENDROBIUM; GENE EXPRESSION REGULATION; HIPPOCAMPUS; LIPOPOLYSACCHARIDES; MALE; MEMORY DISORDERS; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PLANTS, MEDICINAL; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; SIGNAL TRANSDUCTION; TIME FACTORS;

DENDROBIUM; DENDROBIUM MONILIFORME; DENDROBIUM NOBILE; ORCHIDACEAE; RATTUS;

EID: 78651488515     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0030-1250235     Document Type: Article

References (32)

1. Selkoe D J. Alzheimer's disease: genes, proteins, and therapy. Physiol Rev 2001 81 741-766
2. Pratico D, Trojanowski J Q. Inflammatory hypotheses: novel mechanisms of Alzheimer's neurodegeneration and new therapeutic targets? Neurobiol Aging 2000 21 441-445
3. Combs C K., Karlo J C., Kao S C., Landreth G E. beta-Amyloid stimulation of microglia and monocytes results in TNF alpha-dependent expression of inducible nitric oxide synthase and neuronal apoptosis. J Neurosci 2001 21 1179-1188
4. Miklossy J, Kis A, Radenovic A, Miller L, Forro L, Martins R, Reiss K, Darbinian N, Darekar P, Mihaly L, Khalili K. Beta-amyloid deposition and Alzheimer's type changes induced by Borrelia spirochetes. Neurobiol Aging 2006 27 228-236
5. Lee J W., Lee Y K., Yuk D Y., Choi D Y., Ban S B., Oh K W., Hong J T. Neuro-inflammation induced by lipopolysaccharide causes cognitive impairment through enhancement of beta amyloid generation. J Neuroinflammation 2008 5 37
6. Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole G M., Cooper N R., Eikelenboom P, Emmerling M, Fiebich B L., Finch C E., Frautschy S, Griffin W S., Hampel H, Hull M, Landreth G, Lue L, Mrak R, Mackenzie I R., McGeer P L., O'Banion M K., Pachter J, Pasinetti G, Plata-Salaman C, Rogers J, Rydel R, Shen Y, Streit W, Strohmeyer R, Tooyoma I, Van Muiswinkel F L., Veerhuis R, Walker D, Webster S, Wegrzyniak B, Wenk G, Wyss-Coray T. Inflammation and Alzheimer's disease. Neurobiol Aging 2000 21 383-421
7. Sasaki A, Shoji M, Harigaya Y, Kawarabayashi T, Ikeda M, Naito M, Matsubara E, Abe K, Nakazato Y. Amyloid cored plaques in Tg2576 transgenic mice are characterized by giant plaques, slightly activated microglia, and the lack of paired helical filament-typed, dystrophic neurites. Virchows Arch 2002 441 358-367
8. Lim G P., Yang F, Chu T, Chen P, Beech W, Teter B, Tran T, Ubeda O, Ashe K H., Frautschy S A., Cole G M. Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease. J Neurosci 2000 20 5709-5714
9. McGeer E G., McGeer P L. Inflammatory processes in Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry 2003 27 741-749
10. Tabet N, Feldmand H. Ibuprofen for Alzheimer's disease. Cochrane Database Syst Rev 2003 (2) CD004031
11. Stichtenoth D O., Frlich J C. COX-2 and the kidneys. Curr Pharm Des 2000 6 1737-1753
12. Graupera M, Garca-Pagn J C., Abraldes J G., Peralta C, Bragulat M, Corominola H, Bosch J, Rods J. Cyclooxygenase-derived products modulate the increased intrahepatic resistance of cirrhotic rat livers. Hepatology 2003 37 172-181
13. Zhang G N., Zhong L Y., Bligh S W. A., Guo Y L., Zhang C F., Zhang M, Wang Z T., Xu L S. Bi-bicyclic and bi-tricyclic compounds from Dendrobium thyrsiflorum. Phytochemistry 2005 66 1113-1120
14. Wang Q, Gong Q H., Wu Q, Shi J S. Neuroprotective effects of Dendrobium alkaloids on rat cortical neurons injured by oxygen-glucose deprivation and reperfusion. Phytomedicine 2010 17 108-115
15. Chen J W., Ma H, Huang X N., Gong Q H., Wu Q, Shi J S. Improvement of Dendrobium nobile Lindl. alkaloids on cognitive deficit in rats induced by lipopolysaccharides. Chin J Pharmacol Toxicol 2008 22 406-411
16. Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods 1984 11 47-60
17. Gong Q H., Wu Q, Huang X N., Sun A S., Shi J S. Protective effects of Ginkgo biloba leaf extract on aluminum-induced brain dysfunction in rats. Life Sci 2005 77 140-148
18. Min S S., Quan H Y., Ma J, Han J S., Jeon B H., Seol G H. Chronic brain inflammation impairs two forms of long-term potentiation in the rat hippocampal CA1 area. Neurosci Lett 2009 456 20-24
19. Fan L W., Pang Y, Lin S, Tien L T., Ma T, Rhodes P G., Cai Z. Minocycline reduces lipopolysaccharide-induced neurological dysfunction and brain injury in the neonatal rat. J Neurosci Res 2005 82 71-82 (Pubitemid 41604799)
20. Bao X M. Stereotaxic atlas of rat's brain [M]. Beijing People's Medical Publishing House 1991 46-54
21. Zilka N, Ferencik M, Hulin I. Neuroinflammation in Alzheimer's disease: protector or promoter? Bratisl Lek Listy 2006 107 374-383
22. Maccioni R B., Rojo L E., Fernndez J A., Kuljis R O. The role of neuroimmunomodulation in Alzheimer's disease. Ann NY Acad Sci 2009 1153 240-246
23. Rogers J, Mastroeni D, Leonard B, Joyce J, Grover A. Neuroinflammation in Alzheimer's disease and Parkinson's disease: are microglia pathogenic in either disorder? Int Rev Neurobiol 2007 82 235-246
24. Townsend K P., Pratic D. Novel therapeutic opportunities for Alzheimer's disease: focus on nonsteroidal anti-inflammatory drugs. FASEB J 2005 19 1592-1601
25. Tegeder I, Pfeilschifter J, Geisslinger G. Cyclooxygenase-independent actions of cyclooxygenase inhibitors. FASEB J 2001 15 2057-2072
26. Glibetic M, Samlalsingh-Parker J, Raykova V, Ofenstein J, Aranda J V. Group B streptococci and inducible nitric oxide synthase: modulation by nuclear factor kappa B and ibuprofen. Semin Perinatol 2001 25 65-69
27. Richardson R L., Kim E M., Gardiner T, O'Hare E. Chronic intracerebroventricular infusion of lipopolysaccharide: effects of ibuprofen treatment and behavioural and histopathological correlates. Behav Pharmacol 2005 16 531-541
28. Inukai T, Uchida K, Nakajima H, Yayama T, Kobayashi S, Mwaka E S., Guerrero A R., Baba H. Tumor necrosis factor-alpha and its receptors contribute to apoptosis of oligodendrocytes in the spinal cord of spinal hyperostotic mouse (twy/twy) sustaining chronic mechanical compression. Spine (Phila Pa 1976) 2009 34 2848-2857
29. Morrison R S., Kinoshita Y, Johnson M D., Ghatan S, Ho J T., Garden G. Neuronal survival and cell death signaling pathways. Adv Exp Med Biol 2002 513 41-86
30. Kaltschmidt B, Kaltschmidt C. NF- k B in the nervous system. Cold Spring Harb Perspect Biol 2009, advance online publication 1 September 2009
31. Rincn M, Enslen H, Raingeaud J, Recht M, Zapton T, Su M S., Penix L A., Davis R J., Flavell R A. Interferon-gamma expression by Th1 effector T cells mediated by the p38 MAP kinase signaling pathway. EMBO J 1998 7 2817-2829
32. Zhu X, Rottkamp C A., Boux H, Takeda A, Perry G, Smith M A. Activation of p38 kinase links tau phosohorylation, oxidative stress, and cell cycle-related events in Alzheimer disease. J Neuropathol Exp Neurol 2000 59 880-888